Hematopoietic stem cells (HSC) from bone marrow, peripheral blood and cord blood are important in clinical transplantation. However, their use in gene therapy protocols is still limited by a low level of transduction efficiency. In addition to the cell cycling block to retrovirus transduction, we recently demonstrated that the low level of retrovirus receptor mRNA in mouse HSC correlated with the low level of amphotropic retrovirus transduction in these cells. Similarly, we found low levels of mRNA encoding the amphotropic retrovirus receptor in human bone marrow Lin − CD34 + CD38 − HSC. In an effort to identify an alternative population of human HSC that might be more efficiently transduced, we assayed HSC populations from cord blood for mRNA encoding the amphotropic retrovirus receptor. High levels of receptor mRNA were present in HSC from previously cryopreserved cord blood compared with HSC from fresh bone marrow and fresh cord blood. The HSC from cryopreserved cord blood are excellent candidates for gene therapy protocols.
Pluripotent hematopoietic stem cells (PHSC) are a rare population of cells in the yolk sac, fetal liver and adult bone marrow of many species. Their capacity to reconstitute the entire hematopoietic system and to self-renew would seem to make them ideal candidates for gene therapy (Figure 1 ). However, a major obstacle to successful retrovirus-mediated gene therapy for hematopoietic disorders is the low efficiency of gene transfer into human PHSC. Less than 1% of the circulating blood cells derived from PHSC transduced in vitro with amphotropic retroviruses carry the transferred gene (Table 1) . This inefficient transduction is widely considered to be a consequence of the quiescent status (G 0 ) of PHSC (Mulligan. Science 1993; 260: 926) . Our data, based on reverse transcriptase-PCR analysis of amphoR mRNA, suggest that the number of amphotropic retrovirus receptors (amphoR) on the surface of a PHSC determines the efficiency with which it can be transduced (Orlic et al. Proc Natl Acad Sci USA 1996; 93: 11097) .
To identify PHSC populations suitable for amphotropic retrovirus transduction, we have assayed the level of mRNA encoding amphoR in several PHSC populations from both untreated and experimentally manipulated mouse and human hematopoietic tissues. AmphoR mRNA levels in Lin − c-kit Hi PHSC-enriched fractions from mouse fetal liver was slightly lower than the level in unfractionated fetal liver and bone marrow and significantly lower than the positive control NIH-3T3 cells which have a high level of amphoR mRNA and a high amphotropic retroviral transduction efficiency ( 
Figure 1
This model illustrates the capacity of PHSC to differentiate into progenitors for all blood cell lineages. Thus, all blood cells derived from a retrovirally transduced PHSC will carry the transferred gene. Furthermore, since PHSC can self-renew the change will be permanent. The difficulty to date has been the low transduction efficiency of PHSC which is generally thought to be due to the quiescent (G o ) cycling status of PHSC. We hypothesize that a low number of amphotropic retrovirus receptors on PHSC may also be a key factor in the inefficient transduction of the PHSC.
(FR) of 25, 30 and 35 ml/min, lineage subtraction (Lin − ) and flow cytometry based on high/low/negative c-kit expression (c-kit Hi/Lo/Neg ), we have identified a FR25 Lin − c-kit Hi subpopulation of mouse bone marrow-derived PHSC with a low level of amphoR mRNA and low transduction efficiency, and a FR35 Lin − c-kit Hi subpopulation of PHSC with a higher level of amphoR mRNA and a higher transduction efficiency (Table  1 and Figure 2 ). To test the effect of cytokines on retrovirus receptor mRNA expression we gave five daily injections of granulocyte colony-stimulating factor (200 g/kg/day) and stem cell factor (50 g/kg/day) to adult, splenectomized C57BL/6 mice and collected their peripheral blood and bone marrow at 1 and 14 days, respectively, after the last injection of cytokines. This treatment induced a 3-to 10-fold increase in the total number of PHSC per mouse (Bodine et al. Blood 1996; 88: 89) with the majority of the PHSC initially in the peripheral blood and subsequently in bone marrow at day 14 post-treatment. The PHSC mobilized into the peripheral blood at day 1 post-treatment and those in bone marrow at day 14 were transduced 10-to 20-fold more efficiently than PHSC from steady-state bone marrow (Bodine et al. Blood 1994; 84: 1482) . Peripheral blood and bone marrow obtained from cytokine-treated mice were fractionated by CCE into FR25, FR30 and FR35 samples and each of these was further fractionated by flow cytometry to provide a Lin − c-kit Hi population. The circulating PHSC in untreated mice were not a Fetal livers were harvested on day 14.5 of gestation. Eight to 10 fetal livers were assayed in each of three experiments. Bone marrow cells were assayed in three to nine experiments. b Mean ± standard deviation. The receptor mRNA levels were normalized to the level of ␤2-microglobulin in the same sample.
Figure 2
(a) PCR results from two different experiments. ␤-globin DNA was amplified to demonstrate that DNA was present in each PCR reaction. When the stem cell-enriched FR25 Lin − c-kit Hi population was co-transduced with amphotropic and ecotropic retroviruses we found ecotropic provirus DNA in the circulating blood cells of 10 of 13 transplanted mice. In correlation with the low levels of amphotropic receptor mRNA detected in this stem cell population, the amphotropic provirus was detected in only one of 13 mice and this signal was weaker than the ecotropic viral DNA in the same cell population. (b) We then tested the FR35 Lin − c-kit Hi cells in the competitive transduction assay. The results from two separate experiments are seen here. All 11 transplanted mice contained ecotropic provirus detected by PCR of peripheral blood at 16 weeks post-transplant. In contrast to the low level of amphotropic virus transduction of stem cells in the FR25 Lin − c-kit Hi cells, transduction efficiency with amphotropic viruses was greatly improved in the FR35 Lin − c-kit Hi population. The amphotropic proviral fragment was detected in six of 11 transplanted mice. Furthermore, in three of these mice the intensity of the signal for the amphotropic and ecotropic proviruses was comparable (reprinted with permission. Proc Natl Acad Sci USA 1996; 93: 11097). present in sufficient numbers to isolate by CCE and flow cytometry and thus could not be analyzed. In contrast, the high number of PHSC in the peripheral blood of G-CSF and SCFtreated mice enabled us to obtain purified PHSC fractions which were then assayed by reverse transcriptase-PCR for amphoR mRNA levels. There were equivalent levels of amphoR mRNA in mobilized PHSC from peripheral blood and bone marrow. The amphoR mRNA level in PHSC from bone marrow from cytokine-treated mice was 3-to 7-fold higher than the level in the corresponding phenotypic fraction in untreated mouse bone marrow (Orlic et al. Blood 1996 ; 88 (Suppl. 1): 644a).
Human adult bone marrow, umbilical cord blood and peripheral blood from cytokine-treated patients are all suitable sources of PHSC for clinical transplantation. However, when CD34 + cells are isolated from these several sources for retrovirus transduction followed by transplantation, the efficiency of gene transfer is generally less than 1% (Dunbar et al. Blood 1995; 85: 3048; Kohn et al. Nature Med 1995; 1: 1017) . We hypothesized that the basis for the low transduction efficiency of human PHSC may be a low receptor number, similar to our findings for mouse PHSC, and that identification of populations of human PHSC with higher levels of amphoR mRNA may lead to improvement in the efficiency of gene transfer in clinical trials for hematopoietic disorders. − cells from previously cryopreserved umbilical cord blood was 1.55-fold higher than the level in HeLa cells. Thus, the level of amphoR mRNA detected in cryopreserved umbilical cord blood PHSC was 12-fold higher than the fresh umbilical cord blood PHSC and 22-fold higher than the PHSC population in adult bone marrow (Orlic et al. Blood 1997; 90 (Suppl. 1): 116a) .
In summary, we have identified a subset of mouse FR35 Lin − c-kit Hi PHSC that have a high level of amphoR mRNA and a high transduction efficiency. Based on this finding we believe that the increased level of amphoR mRNA in the expanded pool of PHSC in mice treated with G-CSF and SCF suggests that these PHSC may represent improved targets for amphotropic retrovirus-mediated gene transfer protocols and that the mobilized peripheral blood PHSC from patient's receiving G-CSF and/or cytoxin may be improved targets for gene transfer. Likewise, the high level of amphoR mRNA detected in PHSC from cryopreserved umbilical cord blood suggests that these PHSC may also be excellent candidates for gene therapy trials.
